As always, I hope you're right dividendseeker. Sorry to keep beating a dead horse, but the Biotech Index (XBI) is up 29.20% year to date, while CELG is down 0.77% year to date.
I still agree with your long term assessment of its progress, but...
Indeed. XBI (SPDR's S&P Biotech index fund) was up another 1.75% today, while CELG treaded water. CELG was at $114.7 when I finally switched between the two last Friday. Meanwhile, XBI gained 3.43%.
This pattern of the former outpacing the latter has been true for today, the past week, past month, 3 months, YTD, year and 2 years. Hmm...
I was sort of looking for an explanation of why it continues to get its #$%$ handed to it by XBI over every single one of these time periods, why it's supposedly the better choice better of the two. Again, see all the numbers I posted above.
FWIW, CELG lost another 5% relative to XBI this week. Add that to the 3 month, 6 month, 1 year, 2 years and 5 years list figures I listed in the original post. Plus you're taking the additional risk exposure of being tied to a single equity rather than an index. Just sayin'...
Wishing everyone here a great weekend.
Thanks again. Interesting stuff. 65% currently in cash was interesting also.
PS dividendseeker... Any chance I could get you to reveal the other 8? :-)
No harm in asking eh?
Very helpful as usual dividendseeker. I appreciate you taking the time to send such a detailed analysis, as well as the thinking behind both your assessment and the approach you're taking (and have taken). Best of luck to you...
Good stuff trading_pro_broker. Thanks. I may go 50%/50%.
I didn't even bother to include it, but the same holds true over the past month (10.49% vs. 3.62%). Not until you go beyond the previous five years does CELG out begin to out perform it (go back to 10 years and it destroys XBI's performance).
Even aside from all that wouldn't an index fund also have the inherent advantage of not being tied to a single equity? Just askin'
Hi dividendseeker -- good to hear from you as always.
But that relates to only the most recent differencial. As you can see in the rest of my post, CELG has also been outperformed over the past 3 months, 6 months (this period has been particularly ugly -- 34% gain vs. no gain at all), 1 year, 2 years, and even 5 years. Over any of those time periods, you would have been better off holding and/or buying XBI than CELG (just hit the "+ Comparison" option on the CELG chart to the right).
What am I missing here? Thoughts? (Disclosure: I finally switched to it last week because of these relative performance data):
Interesting info -- thanks Keith. FWIW, I don't have any holdings in the stock. I just thought that was as amazing one day move.
Yikes. How's that for a one day pop?
Bingo. You're not alone. Reminds me of the line the girl says in the classic Jamaica based movie The Harder They Come. "Every game I play I lose".
Neglected the Disclosure. Buy and hold Long-Term. Sold at $108, hoping it will drop down a bit from today's $115 so I can hop back in...
Seriously -- if anyone were trying to influence a retail investor's assessment, why would they even bother trying to do it on this board?
Let's say I get you to go long or short on CELG and that affects the way you handle your 1,000 shares, what conceivable effect could that have on CELG's price? Maybe move it one hundred thousandth of a dollar?
I haven't done the math on that, but you see the point. Wouldn't even be worth the time you took to move the mouse.
Good luck to all here...
This was posted on Seeking Alpha at 3:43pm
"Celgene's Revlimid Patent Families Do Not Appear To Meet Criteria For Protection... As a result, the '517 patent should not be entitled to patent protection in the United States or any of the nearly 70 countries where Revlimid® is approved."